Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Diabetes
•
Cardiology
•
Endocrinology
How many days prior to surgery do you recommend stopping SGLT2 inhibitors and when is it safe to resume therapy?
Related Questions
Should we recommend SGLT2i initiation at discharge to all patients hospitalized with acute myocardial infarction?
Do you recommend adding low-dose Aspirin for primary prevention in patients with Type 2 Diabetes on Eliquis for another indication?
Is ABI (Ankle Brachial index) lower limb arterial doppler not recommended if patient already has arterial stents in the legs, and if so, what other imaging modality would you consider as first-line?
Are recurrent UTIs a contraindication to SGLT2i use?
When do you refer a patient with MODY3 to GI/Hepatology for monitoring/management of hepatic adenomas?
Under what circumstances would you test for hypercortisolism in a patient with insulin resistance?
Should low-intensity statins be favored to minimize the risk of diabetes onset while still offering cardiovascular benefit for patients with prediabetes where a statin is indicated?
What are the potential causes for significant discrepancies between predicted A1c by Dexcom CGM and standard serum A1c by lab draw?
Would you consider using Evenity is an elderly patient with rate controlled atrial fibrillation without history of MI or CVA?
Is Metformin contraindicated in patients using long term oxygen therapy at home?
